Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (231-240 of 625) with videos related to

Pageof 63
Sort By:
Clinical and Experimental Rheumatology|October 2, 2012
Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosisMaria Grazia Catanoso, Lucia Spaggiari, Luca Magnani, et al.
BMC Pulmonary Medicine|December 11, 2023
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseasesFabrizio Luppi, Andreina Manfredi, Paola Faverio, et al.
Arthritis Care & Research|December 22, 2017
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?Francesco Muratore, Tanaz A Kermani, Cynthia S Crowson, et al.
Nature Reviews. Rheumatology|May 20, 2026
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoidsFrancesco Muratore, Kenneth J Warrington, Christian Dejaco, et al.
Arthritis Care & Research|May 24, 2016
Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year PeriodMariagrazia Catanoso, Pierluigi Macchioni, Luigi Boiardi, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Clinical and Experimental Rheumatology|April 27, 2019
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritisNicolo Pipitone, Francesco Muratore, Ione Tamagnini, et al.
Arthritis and Rheumatism|August 1, 2008
Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence riskLia Pulsatelli, Luigi Boiardi, Elettra Pignotti, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|April 2, 2021
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference CenterAmelia Spinella, Luca Magnani, Marco De Pinto, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issuesSalvatore D'Angelo, Carlo Palazzi, Fabrizio Cantini, et al.
Pageof 63

Showing results (231-240 of 625) with videos related to

Sort By:
Pageof 63
Clinical and Experimental Rheumatology|October 2, 2012
Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosisMaria Grazia Catanoso, Lucia Spaggiari, Luca Magnani, et al.
BMC Pulmonary Medicine|December 11, 2023
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseasesFabrizio Luppi, Andreina Manfredi, Paola Faverio, et al.
Arthritis Care & Research|December 22, 2017
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?Francesco Muratore, Tanaz A Kermani, Cynthia S Crowson, et al.
Nature Reviews. Rheumatology|May 20, 2026
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoidsFrancesco Muratore, Kenneth J Warrington, Christian Dejaco, et al.
Arthritis Care & Research|May 24, 2016
Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year PeriodMariagrazia Catanoso, Pierluigi Macchioni, Luigi Boiardi, et al.
Arthritis and Rheumatism|August 12, 2003
Efficacy of infliximab in resistant psoriatic arthritisCarlo Salvarani, Fabrizio Cantini, Ignazio Olivieri, et al.
Clinical and Experimental Rheumatology|April 27, 2019
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritisNicolo Pipitone, Francesco Muratore, Ione Tamagnini, et al.
Arthritis and Rheumatism|August 1, 2008
Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence riskLia Pulsatelli, Luigi Boiardi, Elettra Pignotti, et al.
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|April 2, 2021
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference CenterAmelia Spinella, Luca Magnani, Marco De Pinto, et al.
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issuesSalvatore D'Angelo, Carlo Palazzi, Fabrizio Cantini, et al.
Pageof 63